J Korean Med Assoc.  2004 Nov;47(11):1063-1069. 10.5124/jkma.2004.47.11.1063.

Lyme Disease

• Lee MG
• Cho YH

• KMID: 1957919
• DOI: http://doi.org/10.5124/jkma.2004.47.11.1063

Abstract

Lyme disease is a vector-borne infection primarily transmitted by Ixodes ticks and is caused by at least three different but closely related species of borrelia. Although it is the most common arthropod-borne disease in the U.S. and Europe, reports of the clinical cases have been relatively rare in Korea. The disease may affect different organs, such as nervous system, joints, heart or eyes, and the clinical pictures include meningitis, cranial neuritis, arthritis, temporary atrioventricular block, and conjunctivitis. The cutaneous manifestations are erythema(chronicum) migrans, borrelial lymphocytoma, and acrodermatitis chronica atrophicans. Early localized infection occurs a few weeks after a tick bite, and erythema migrans is a classic cutaneous manifestation at this stage of infection. Several weeks later, early disseminated infection occurs with bacterial dissemination. Multiple erythema migrans-like skin lesions, neuroborreliosis, arthritis, and carditis can develop. Without treatment, the disease can progress to late or chronic infection, and then acrodermatitis chronica atrophicans may develop in addition to the systemic manifestations. The disease can be diagnosed with serologic tests such as indirect immunofluorescence test or ELISA. The recommended treatment is oral doxycycline or amoxicillin, and the treatment period is variable depending on the organ involved and the duration of the disease. A vaccine for the Lyme disease is approved for adults and commercially available in the Unites States. However, protection from tick bites by the use of protective clothing in risk areas and body inspection and removal of any attached ticks as soon as possible are the most important prophylactic methods. Chemoprophylaxis after a tick bite is also available.

Keyword

Borrelia burgdorferi; Ixodes; Erythema migrans; Borrelia lymphocytoma; Acrodermatitis chronica atrophicans

MeSH Terms

Acrodermatitis
Adult
Amoxicillin
Arthritis
Atrioventricular Block
Borrelia
Borrelia burgdorferi
Chemoprevention
Conjunctivitis
Doxycycline
Enzyme-Linked Immunosorbent Assay
Erythema
Europe
Fluorescent Antibody Technique, Indirect
Heart
Humans
Ixodes
Joints
Korea
Lyme Disease*
Meningitis
Myocarditis
Nervous System
Neuritis
Protective Clothing
Pseudolymphoma
Serologic Tests
Skin
Tick Bites
Ticks
Amoxicillin
Doxycycline

Reference

1. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease-a tick-borne spirochetosis? Science. 1982. 216:1317–1319.

4. Kim TH, Choi EH, Lee MG, Ahn SK. Serologically diagnosed Lyme disease manifesting erythema migrans in Korea. J Korean Med Sci. 1999. 14:85–88.

7. Steere AC. Lyme disease. N Eng J Med. 2001. 345:115–125.

8. Abele DC, Anders KH. The many faces and phases of borreliosis I. Lyme disease. J Am Acad Dermatol. 1990. 23:167–186.

9. McGinley-Smith DE, Tsao SS. Dermatoses from ticks. J Am Acad Dermatol. 2003. 49:363–392.

10. Barbour A. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med. 1984. 57:521–525.

11. Johnson BJ, Robbins KE, Bailey RE, Cao B, Sviat SL, Craven RB, et al. Serodiagnosis of Lyme disease:accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis. 1996. 174:346–353.

12. Asbrink E, Hovmark A, Hederstedt B. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays. Acta Derm Venereol. 1985. 65:509–514.

13. Hansen K, Asbrink E. Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay. J Clin Microbiol. 1989. 27:545–551.

14. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet. 1998. 352:557–565.

15. Melsky JW. Lyme borreliosis. Semin Cutan Med Surg. 2000. 19:10–18.

16. Ma B, Christen B, Leung D, Vigo-Pelfrey C. Serodiagnosis of Lyme borreliosis by Western immunoblot:reactivity of various significant antibodies against Borrelia burgdorferi. J Clin Microbiol. 1992. 30:370–376.

17. Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Krause DS. Lyme Disease Vaccine Study Group. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med. 1998. 339:209–215.

18. Korenberg EI, Vorobyeva NN, Moskvitina HG, Gorban' LYa. Prevention of borreliosis in persons bitten by infected ticks. Infection. 1996. 24:187–189.

19. Nadelman RB, Nowakowski J, Fish D, Falco RC, Freeman K, Wormser GP. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med. 2001. 345:79–84.

20. Shapiro ED. Doxycycline for tick bites-not for everyone. N Engl J Med. 2001. 345:133–134.

21. Asbrink E, Olsson I. Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients. A comparison with Lyme disease. Acta Derm Venereol. 1985. 65:43–52.

22. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med. 1987. 107:725–731.

23. Weber K, Preac-Mursic V, Neubert U, Thurmayr R, Herzer P, Marget W. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Ann N Y Acad Sci. 1988. 539:324–345.

24. Steere AC, Hutchinson GJ, Rahn DW, Sigal LH, Craft JE, Malawista SE. Treatment of the early manifestations of Lyme disease. Ann Intern Med. 1983. 99:22–26.